Most importantly, via association with and stabilization of CMTM6, HuR was shown to upregulate cancer cell surface PD-L1 with exposure to IFN-γ, which was potently blockaded by HuR-specific inhibitor. The gene discussed is ELAVL1; the disease is cancer.